Protagenic Therapeutics, Inc.new
Price data unavailable
Track PTIX in your trading journalAbout Protagenic Therapeutics, Inc.new
Protagenic Therapeutics, Inc.new (PTIX) is a publicly traded US company. PROTAGENIC THERAPEUTICS
The company reports trailing twelve-month revenue of $0 and net income of $2.21M.
Key metrics include a return on equity of -92.4%, a debt-to-equity ratio of -2.85.
Investors tracking PTIX can follow price movements, analyst estimates, and fundamental changes directly through FINOTAUR's research tools.
Fundamentals
| Revenue (TTM) | $0 |
| Net Income (TTM) | $2.21M |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | -92.40% |
| Debt-to-Equity | -2.85 |
| Dividend per Share | — |
Recent News
- Benzinga·Mar 23
Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- Benzinga·Dec 30
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
- GlobeNewswire Inc.·Aug 30
Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ET
Want real-time analysis on PTIX?
Track it free in your trading journal. Log trades, tag setups, and review your edge.